Murday, V.

cancer starch breast cancer colorectal cancer brca 1 brca 2 mutations breast colorectal e ffect chek 2*1100delc family participant mutation study analysis individual placebo 2*1100delc fi bre syndrome resistant-starch 2 years syndrome cancers e ffects intervention follow-up capp 2 study aspirin chek 2 group table control genetic resistant-starch placebo variant randomisation carrier research evidence frequency ratio university incidence intake patient number exit colonoscopy hospital trial prevention hazard breast cancer risk intervention phase brca 2 netherland report month signi randomised centre poisson regression starch <2 years treatment appendix bowel hazards analysis colon breast cancer unselected nature duration capp 2 investigators susceptibility department allele chromosome adenomas marker linkage per-protocol intention-to-treat